DeSimone Jill 4
4 · iTeos Therapeutics, Inc. · Filed Mar 7, 2024
Insider Transaction Report
Form 4
DeSimone Jill
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-07+44,766→ 44,766 totalExercise: $11.58Exp: 2034-03-07→ Common Stock (44,766 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 3 years, with 1/3 vesting on March 7, 2025, and thereafter in equal monthly installments over the next 24 months, subject to the Reporting Person's continued service as a director through the applicable vesting date.